INFUSYSTEM HOLDINGS, INC Accounts Receivable, Allowance for Credit Loss, Recovery
INFUSYSTEM HOLDINGS, INC (INFU) reported Accounts Receivable, Allowance for Credit Loss, Recovery of $5.38 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-22.
Discontinued › Notes › Receivables › Accounts, Notes, Loans and Financing Receivable, Gross, Allowance, and Net
us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries · last filed 2017-03-22
- INFUSYSTEM HOLDINGS, INC accounts receivable, allowance for credit loss, recovery for fiscal 2016 was $5.38M, a 2.73% increase from fiscal 2015.
- INFUSYSTEM HOLDINGS, INC accounts receivable, allowance for credit loss, recovery for fiscal 2015 was $5.24M, a 9.86% decline from fiscal 2014.
- INFUSYSTEM HOLDINGS, INC accounts receivable, allowance for credit loss, recovery for fiscal 2014 was $5.81M.
- INFUSYSTEM HOLDINGS, INC accounts receivable, allowance for credit loss, recovery for fiscal 2013 was -$4.90M.
| Period end | Accounts Receivable, Allowance for Credit Loss, Recovery 12 month | Accounts Receivable, Allowance for Credit Loss, Recovery 12 month as first filed |
|---|---|---|
| 2016-12-31 | $5.38M 10-K · filed 2017-03-22 | |
| 2015-12-31 | $5.24M 10-K · filed 2017-03-22 | |
| 2014-12-31 | $5.81M 10-K/A · filed 2016-12-12 | -$5.81M 10-K · filed 2015-03-09 |
| 2013-12-31 | -$4.90M 10-K · filed 2015-03-09 | |
| 2012-12-31 | -$3.89M 10-K · filed 2014-03-11 | $3.89M 10-K · filed 2013-03-28 |
| 2011-12-31 | $4.12M 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |